Literature DB >> 6420824

Methysergide and metergoline reduce morphine analgesia with no effect on the development of tolerance in rats.

S Romandini, R Samanin.   

Abstract

A single subcutaneous injection of 5 mg/kg metergoline or 10 mg/kg methysergide, two serotonin antagonists, or 1 mg/kg naloxone, significantly reduced the effect of a subcutaneous dose of 3 mg/kg morphine in the tail immersion test in rats. The same drugs and doses were administered concurrently with 10 mg/kg morphine twice daily for 3 days and nociceptive responses were measured 96 h later. Tolerance to the effect of 3 mg/kg morphine was comparable in animals which had received vehicle + morphine or serotonin antagonists + morphine, whereas naloxone completely prevented the development of tolerance. The results argue against a role of serotonin in the development of tolerance to the antinociceptive effect of morphine and suggest it may be possible to dissociate morphine analgesia from tolerance development, at least in the conditions used in the present study.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420824     DOI: 10.1007/bf00426398

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  Prostaglandins: antinociceptive effect of prostaglandin E1 in the rat.

Authors:  A K Sanyal; S K Bhattacharya; P R Keshary; D N Srivastava; P K Debnath
Journal:  Clin Exp Pharmacol Physiol       Date:  1977 May-Jun       Impact factor: 2.557

2.  Involvement of the periaqueductal grey matter and spinal 5-hydroxytryptaminergic pathways in morphine analgesia: effcts of lesions and 5-hydroxytryptamine depletion.

Authors:  J F Deakin; J O Dostrovsky
Journal:  Br J Pharmacol       Date:  1978-05       Impact factor: 8.739

3.  Effects of 5,6-dihydroxytryptamine on monoaminergic neurones in the central nervous system of the rat.

Authors:  H G Baumgarten; K D Evetts; R B Holman; L L Iversen; M Vogt; G Wilson
Journal:  J Neurochem       Date:  1972-06       Impact factor: 5.372

4.  Decrease of tolerance development to morphine by 5-hydroxytryptophan and some related drugs.

Authors:  E Contreras; L Tamayo; L Quijada; E Silva
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

5.  The effect of p-chlorophenylalanine on opiate-induced running, analgesia, tolerance and physical dependence in mice.

Authors:  D L Cheney; A Goldstein
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

6.  Studies on the relationship between 5-hydroxytryptamine turnover in brain and tolerance and physical dependence in mice.

Authors:  Y Maruyama; G Hayashi; S E Smits; A E Takemori
Journal:  J Pharmacol Exp Ther       Date:  1971-07       Impact factor: 4.030

7.  Influence of 5,6-dihydroxytryptamine on morphine tolerance and physical dependence.

Authors:  I K Ho; H H Loh; E L Way
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

8.  Antagonism of the analgesic effect of morphine and other drugs by p-chlorophenylalanine, a serotonin depletor.

Authors:  S S Tenen
Journal:  Psychopharmacologia       Date:  1968

9.  The effect of lowering the 5-hydroxytryptamine content of the rat spinal cord on analgesia produced by morphine.

Authors:  M Vogt
Journal:  J Physiol       Date:  1974-01       Impact factor: 5.182

10.  Evidence of a preferential role of brain serotonin in the mechanisms leading to naloxone-precipitated compulsive jumping in morphine-dependent rats.

Authors:  L Cervo; C Rochat; S Romandini; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more
  3 in total

1.  Identification of STXBP6-IRF1 positive feedback loop in regulation of PD-L1 in cancer.

Authors:  Yanbin Liu; Zhicong Huang; Yanli Wei; Mingming Zhang; Xingzhi Li; Shulan Yang; Haihe Wang
Journal:  Cancer Immunol Immunother       Date:  2020-07-22       Impact factor: 6.968

2.  Immune tumor board: integral part in the multidisciplinary management of cancer patients treated with cancer immunotherapy.

Authors:  Heinz Läubli; Stefan Dirnhofer; Alfred Zippelius
Journal:  Virchows Arch       Date:  2018-08-25       Impact factor: 4.064

Review 3.  Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy.

Authors:  Alessandra Tuccitto; Eriomina Shahaj; Elisabetta Vergani; Simona Ferro; Veronica Huber; Monica Rodolfo; Chiara Castelli; Licia Rivoltini; Viviana Vallacchi
Journal:  Virchows Arch       Date:  2018-10-29       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.